Journal of Clinical Microbiology and Antimicrobials
Open Access

Enterovirus Infections: Prevention Strategies for High-Risk Populations

Fatima Guez^{* *}Correspondence: Fatima Guez, Department of Microbiology, University Hospital Aachen, Aachen, Germany, Email:

Author info »

Description

Enteroviruses are a group of viruses that can cause a wide range of illnesses, from mild symptoms like respiratory infections and gastroenteritis to severe conditions such as meningitis, encephalitis and myocarditis. These infections, particularly in high-risk populations, can lead to significant morbidity and mortality. High-risk populations include infants, the elderly, individuals with weakened immune systems and those with chronic health conditions such as asthma or cardiovascular disease. While most enterovirus infections are self-limiting, the potential for severe complications in these vulnerable groups calls for targeted prevention strategies. This study discusses prevention approaches for enterovirus infections in high-risk populations, focusing on vaccination, hygiene practices, public health interventions and monitoring.

Impacts of enterovirus infections

Poliovirus, coxsackievirus, echovirus and enterovirus A, B, C and D. These viruses are typically transmitted through the fecal-oral route, respiratory droplets, or contact with contaminated surfaces. Enterovirus infections can cause a variety of symptoms, ranging from mild to life-threatening, depending on the strain of the virus and the host's health status. The most common enterovirus-related illnesses include:

Respiratory infections: Such as common colds and pneumonia.

Neurological infections: Meningitis and encephalitis, which are more severe and often seen in high-risk populations.

Myocarditis: Inflammation of the heart muscle, more common in immunocompromised patients or those with underlying heart conditions. Due to their potential to cause severe complications, enteroviruses are a significant concern for high-risk populations, which necessitates the development and implementation of effective prevention strategies.

Strategies for high-risk populations

Vaccination remains the fundamental of preventing certain enterovirus infections, particularly in cases where vaccines are available. While there is no universal vaccine for all enterovirus strains, several vaccines target specific types of enteroviruses. Poliovirus, a member of the enterovirus family, is one of the most well-known enteroviruses. The polio vaccine (inactivated polio vaccine, IPV) is highly effective in preventing poliovirus infections, which can cause irreversible paralysis and death. Although poliovirus is not as widespread due to extensive global vaccination efforts, individuals traveling to areas with active transmission or who are immunocompromised should receive the vaccine to reduce the risk. There are no licensed vaccines for coxsackievirus or echovirus at present. However, research into vaccine development for these enteroviruses is ongoing, with some progress in creating vaccines that could potentially protect individuals from severe infections, particularly in immunocompromised individuals. Until vaccines are available, preventing these infections relies on hygiene and public health measures. Personal hygiene plays an important role in preventing the spread of enteroviruses, particularly in high-risk groups. Education on hygiene practices is essential for caregivers, healthcare providers, and at-risk individuals. People with known enterovirus infections should avoid close contact with vulnerable individuals, particularly newborns, the elderly and those with weakened immune systems, to reduce the risk of transmission. Effective public health interventions are important for managing enterovirus outbreaks and preventing infections in high-risk populations. Governments and healthcare systems play a pivotal role in reducing the incidence of enterovirus infections. Surveillance is essential for identifying and tracking enterovirus outbreaks. Early detection allows for timely intervention, including isolation of infected individuals, public health advisories and mobilization of resources for the affected regions. Monitoring enterovirus prevalence can also provide insight into emerging strains that may pose greater risks to vulnerable populations. Educating the public about the risks of enterovirus infections and the importance of hygiene practices is key to reducing transmission. Awareness campaigns should focus on high-risk groups, including parents of young children, healthcare providers and the elderly, emphasizing the importance of vaccination, hand hygiene and respiratory precautions. In healthcare settings, especially in Intensive Care Units (ICUs) and transplant centers, isolating patients with enterovirus infections can help prevent outbreaks. Isolation protocols should be followed strictly to reduce the risk of nosocomial (hospitalacquired) infections in vulnerable patients. Special attention should be given to high-risk patients such as organ transplant recipients, cancer patients undergoing chemotherapy and those with chronic health conditions. These patients are at higher risk of severe enterovirus infections and may require additional preventive measures such as prophylactic antiviral therapy or enhanced surveillance. Enterovirus infections present a significant risk to high-risk populations, including infants, the elderly and immunocompromised individuals. Preventing these infections requires a multi-faceted approach that includes vaccination, stringent hygiene practices, public health interventions and targeted care for vulnerable individuals. While there are no vaccines for all enterovirus strains, ongoing research into vaccine development and antiviral treatments may offer more preventive options in the future. In the meantime, healthcare providers and public health authorities must continue to educate at-risk groups about effective prevention strategies to minimize the impact of enterovirus infections on these vulnerable populations.